Hepatitis C virus NS5B drug resistance assay-994

Test info

  
Hepatitis C virus NS5B drug resistance assay
  
994
  
LAB994
  
MSO
  
HCV drug resistance
HCV
NS5B drug resistance assay
NS5B resistance analysis
  

Assessment of drug susceptibility by nucleic acid sequencing of a patient's hepatitis C virus (HCV) to the NS5B inhibitors. Assay should be used for patients with documented HCV genotype 1

Specimen

  
Serum
  

Gold serum separator (SST) tube x2

  
2.0 mL
  
1.0 mL
  

Immediately following collection, thoroughly mix sample by gently inverting 5 times

  
  1. Allow sample to clot for a minimum of 30 minutes
  2. Spin within six (6) hours of collection
  3. Remove serum and transfer to a Screw-cap polypropylene frozen transport vial/tube - 4mL (LabCorp), labelled as serum
  4. Freeze
  

Screw-cap polypropylene frozen transport vial/tube - 4mL (LabCorp)

  

Red serum vial/tube, 5 mL x2

  
  1. Allow sample to clot 
  2. Spin 
  3. Remove serum and transfer to a Screw-cap polypropylene frozen transport vial/tube - 4mL (LabCorp), labelled as serum, within six (6) hours of collection
  4. Freeze
  
  • Indicate the patient's HCV genotype (1a or 1b) on the test request form
  

Frozen

  
  • Insufficient volume
  • Heparinized plasma
  •  Non-frozen specimens
  • Specimens exposed to repeated freeze/thaw cycles
  • Specimen received in "pop-top" or "snap- cap" tube

 

Performance

  
Monogram Biosciences ( ) via LabCorp (550505): R-NX
  
Varies
  
15 days
  

Polymerase chain reaction (PCR) amplification and DNA next generation sequencing

Clinical and Interpretive info

  

An interpretive report will be provided

Billing

  
87902
87900
  
Result 72862-6

Tracking

  
05/29/2019
  
04/12/2022
  
04/12/2022